Studies

Patient involvement is essential to offer quality oncology care and to advance oncology care research.

The digital patient self-reported symptoms enable regular evaluation of patient’s symptoms and condition and improve the efficiency and the quality of medical care.

The benefit of electronic tools (smart applications) is to promote the success of cancer therapy, to reduce the physical toxicity of therapy, to maintain the quality of life of the patient, within the family and in the society. Digital health increases patient’s communication with the treating physicians, within or outside the oncology team and structure and reduces the economic costs of cancer therapy.

The benefits of e-health and patients’ wishes are reflected in the written words by Paula Miller, February 2019. “It is very important to create an electronic file, a system for scheduling, organizing and archiving. When the disease progresses and at the same time the patient works, the organization of appointments, check-ups and medical results are absolutely necessary.

At CureCancer:

Patients

• create their medical history, which can share with their physician

• self-report their symptoms and share them with their physicians

• increase the success of therapy and maintain their quality of life

Live longer and better!

Oncologists and related professionals, involved in oncology care

• monitor their patients, are well informed on their symptoms and provide the appropriate, timely and effective treatment.

• reduce the complications and the economic costs of treatment

• increase the success of therapy

Maintain the quality of life for their patients!

_______________________________________________

STUDIES

Exploring the Use of a Digital Platform for Cancer Patients to Report Their Demographics, Disease and Therapy Characteristics, Age, and Educational Disparities: An Early-Stage Feasibility Study. Dimitra Galiti, Helena Linardou, Sofia Agelaki, Athanasios Karampeazis, Nikolaos Tsoukalas, Amanda Psyrri, Michalis Karamouzis, Konstantinos N. Syrigos, Alexandros Ardavanis, Ilias Athanasiadis, Eleni Arvanitou, Stavroula Sgourou, Anastasia Mala, Christos Vallilas, and Ioannis Boukovinas. Curr. Oncol. 2023, 30(8), 7608-7619; https://doi.org/10.3390/curroncol30080551

Oral Toxicities in Cancer Patients, Who Receive Immunotherapy: A Case Series of 24 Patients. Ourania Nicolatou-Galitis, Amanda Psyrri, Nikolaos Tsoukalas, Evangelos Galitis, Helena Linardou, Dimitra Galiti, Ilias Athansiadis, Despoina Kalapanida, Evangelia Razis, Nikolaos Katirtzoglou, Nikolaos Kentepozidis, Paraskevas Kosmidis, Flora Stavridi, Efthimios Kyrodimos, Danai Daliani, George Tsironis, Giannis Mountzios, Sofia Karageorgopoulou, Panagiotis Gouveris,  and Konstantinos Syrigos. Oral 2023, 3(1), 123-133; https://doi.org/10.3390/oral3010011

Disease management in oncology patients under treatment using the digital tool CureCancer and appraisal of the quality of their lives. Master’s Diploma, Graduate Student: Chrysi Sopasi. Hellenic Mediterranean University - ELMETA, Crete, Greece, School of Health Sciences – Nursing Department –  Graduate Studies Program “Advanced Clinical Practice on Health Sciences”.  In cooperation with Clinic "Asklepeion Crete", Heraklion, Crete, Dr. Zenia Saridaki - Zoras, Medical Oncologist.